Ritgens Maneuver for the Prevention of Anal Sphincter Tears at Delivery: A Randomized Controlled Trial
Launched by LUND UNIVERSITY HOSPITAL · Apr 1, 2008
Trial Information
Current as of May 05, 2025
Completed
Keywords
ClinConnect Summary
This application is made retroactively - the study was performed during December 1st, 1999 to July 31st, 2001, at Lund University Hospital and Helsingborg Hospital. Primigravid women in the area were informed about the study at the maternity care centers, receiving written information in gestational week 36. Eligible for the study were women with singleton pregnancy and a fetus in cephalic presentation, admitted for labor, rupture of the membranes or induction after 37 completed gestational weeks. Primigravid women received written information about the study at the maternal health care cen...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women with singleton pregnancy and a fetus in cephalic presentation
- • admitted for labor
- • rupture of the membranes or induction after 37 completed gestational weeks
- • and reaching full cervical dilatation.
- Exclusion Criteria:
- • Operative delivery
About Lund University Hospital
Lund University Hospital, affiliated with Lund University in Sweden, is a leading institution in medical research and clinical trials. Renowned for its commitment to advancing healthcare through innovative research, the hospital integrates clinical practice with academic excellence. As a sponsor of clinical trials, Lund University Hospital focuses on a wide range of therapeutic areas, striving to improve patient outcomes by rigorously evaluating new treatments and interventions. With a multidisciplinary team of expert researchers and clinicians, the hospital emphasizes ethical standards, patient safety, and scientific integrity in all its studies, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Helsingborg, , Sweden
Lund, , Sweden
Patients applied
Trial Officials
Andreas Herbst, MD, PhD
Principal Investigator
Lund University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials